OCEA

Ocean Biomedical, Inc.

Healthcare · Biotechnology

$213.47 sample

-1.20 (-0.56%) 1D

Market cap

$316.9B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-24

Alerts

8

Price$213.47 -2.19% 3M daily closessample

224.23203.71

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: Chief Executive Officer
Sep 24SECForm 144 filed
Sep 17INSInsider sell: 10% owner
Sep 10SEC8-K filed: material event
Sep 02SECDEF 14A filed
Aug 26INSInsider sell: General Counsel
Aug 19INSInsider sell: EVP, Operations
Aug 11INSInsider sell: Director

Sign up to see the real OCEA record →

Company facts

SEC EDGAR registration

Name: Ocean Biomedical, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -45sample, -100 to +100
Reporting currency: USD

Who is positioning in OCEA

sample

Insiders: 35 insider transactions over 90 days, net selling, $599.3M
Congress: No member trades over 90 days
Institutions · 13F: 30 funds hold $1.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.0B +12.8% y/y

Q4 2024Q3 2026

Inventory$11.6B +12.0% y/y

Q4 2024Q3 2026

Accounts receivable$8.9B +17.7% y/y

Q4 2024Q3 2026

Total debt$24.3B +11.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $293.2B -8.5% 3M
Sample peer B: $164.6B +11.8% 3M
Sample peer C: $76.9B -7.4% 3M
Sample peer D: $207.7B +2.3% 3M
Sample peer E: $162.5B +4.5% 3M